CMS advises Brenntag on acquisition of Leis Polytechnik and ACU PHARMA und CHEMIE

Düsseldorf – CMS has advised Brenntag, the global market leader in chemical distribution, on all aspects of two transactions.

In the first project, Brenntag acquired Leis Polytechnik polymere Werkstoffe GmbH. The transaction was completed after receiving merger control approval. Leis Polytechnik specialises in the development, production and distribution of high-performance polymer compounds. The company supplies around 700 products for a wide range of applications across many industries in Germany, including the automotive sector, electronics, medical technology, packaging and construction.

In the second transaction, Brenntag acquired the ACU PHARMA und CHEMIE Group. ACU specialises in the milling and micronisation of products and compound mixtures. In its state-of-the-art facility, the company produces high-quality powders for customers operating in a number of industries. In addition to this customer-specific contract manufacturing, ACU sells its own micronised products, primarily lithium carbonate.

CMS Germany
Dr Thomas Meyding, Client Relationship Partner
Dr Dirk Jannott, Lead Partner
Dr Tobias Grau
Paul Rode, all M&A
Philipp Schönnenbeck, Real Estate
Andreas Josupeit, Employment
Peter Giese, Competition
Kai-Oliver Giesa, Commercial
Andreas Grunert, Banking
CMS Switzerland
Stefan Brunnschweiler
Andrea Ferchl, both M&A
Brenntag

Press contact
presse@cms-hs.com